Showing results (1201-1210 of 4,514) with videos related to

Sort By:
Pageof 452
Future Oncology (London, England)|February 9, 2018
Lung cancer: a brief review of epidemiology and screeningCláudia Gouvinhas, Ramon Andrade De Mello, Daniela Oliveira, et al.
Future Oncology (London, England)|March 9, 2018
Thermal ablation versus surgical resection for localized hepatocellular carcinoma: a population study using the SEER databaseAbigail Mills, David Thayer, Christopher Noda, et al.
Future Oncology (London, England)|February 22, 2018
Pembrolizumab and its use in the treatment of recurrent or metastatic head and neck cancerSiddharth Sheth, Jared Weiss
Future Oncology (London, England)|March 7, 2018
Background and rationale of the eXalt3 trial investigating X-396 in the treatment of ALK+ non-small-cell lung cancerEric K Singhi, Leora Horn
Future Oncology (London, England)|December 12, 2017
Survival prediction in pancreatic cancer patients with no distant metastasis: a large-scale population-based estimateNing Pu, Yang Lv, Guochao Zhao, et al.
Future Oncology (London, England)|October 7, 2017
Cancer-directed therapy and potential impact on survivals in nonresected hepatocellular carcinoma: SEER-Medicare population studyNima Kokabi, Richard Duszak, Minzhi Xing, et al.
Future Oncology (London, England)|October 13, 2017
Trabectedin mechanism of action and platinum resistance: molecular rationaleIsabelle Ray-Coquard
Future Oncology (London, England)|July 7, 2016
A place for precision medicine in bladder cancer: targeting the FGFRsErica di Martino, Darren C Tomlinson, Sarah V Williams, et al.
Future Oncology (London, England)|January 9, 2019
Critical systematic review on hepatic resection and transarterial chemoembolization for hepatocellular carcinomaLeonardo Solaini, Alessandro Cucchetti, Marco Piccino, et al.
Future Oncology (London, England)|March 27, 2007
Role of bevacizumab for the treatment of non-small-cell lung cancerSuresh Ramalingam, Chandra P Belani
Pageof 452